The orthopaedics device maker, through a collaboration with Canary Medical, becomes the first company to bring an implantable smart device for total knee replacement to the U.S. market. | Wall Street analysts and investors had previously questioned the price and strategic fit of a deal, which was rumored for weeks. | The clinical trial of the CardioMEMS implantable sensor in a wider patient population missed its primary goal, but the company is moving forward based on an analysis adjusted for the pandemic. | Wall Street analysts were not surprised by the results given the recent FDA approval for Amulet, but agreed that the data was strong enough to boost the left atrial appendage closure products from Abbott and Boston Scientific. | With marijuana use rising quickly in U.S. adults aged 45 to 64 years, three studies presented at the American Academy of Orthopaedic Surgeons meeting sought to find out if consumption affects outcomes. | From Our Library View all resources Best of What We're Reading Wall Street Journal | The New York Times | MobiHealthNews | MedCity News | Vox | Axios | Dive Into a Topic | |
0 Comments